948 Results

People

  1. Kelsen
    Kelsen
  2. Kris
    Kris
  3. Kemeny
    Kemeny
  4. Scher
    Scher
  5. Heelan
    Heelan
  6. Saltz
    Saltz
  7. Bajorin
    Bajorin
  8. Bosl
    Bosl
  9. Casper
    Casper
  10. Gralla
    Gralla

Groups

  1. Department of Medicine (389)
  2. Solid Tumor Oncology Division (295)
  3. Sloan Kettering Institute Faculty (141)
  4. Gastrointestinal Oncology Service (120)
  5. Survivorship Research (116)
  6. Molecular Pharmacology and Chemistry Program Faculty (107)
  7. Surgery (102)
  8. Nursing (87)
  9. Center for Pancreatic Cancer Research (80)
  10. GSK Faculty (80)
  1. "intravenous drug administration"
Formats
  1. Journal Article (883)
  2. Conference Paper (54)
  3. Review (7)
  4. Meeting Abstract (2)
  5. Guidelines (1)
  6. Research Letter (1)
Groups
  1. Department of Medicine (389)
  2. Solid Tumor Oncology Division (295)
  3. Sloan Kettering Institute Faculty (141)
  4. Gastrointestinal Oncology Service (120)
  5. Survivorship Research (116)
  6. Molecular Pharmacology and Chemistry Program Faculty (107)

More Groups

People
  1. David Kelsen (73)
  2. Mark Kris (55)
  3. Nancy Kemeny (49)
  4. George Bosl (40)
  5. Howard Scher (38)
  6. Robert Heelan (37)

More People

Years
  1. 2025 (1)
  2. 2024 (8)
  3. 2023 (3)
  4. 2022 (3)
  5. 2021 (2)
  6. 2020 (1)

More Years

Publications
  1. Journal of Clinical Oncology (109)
  2. Cancer (86)
  3. Cancer Treatment Reports (35)
  4. Seminars in Oncology (29)
  5. Cancer Research (26)
  6. Cancer Investigation (20)

More Publications

Publishers
  1. Elsevier Inc. (111)
  2. American Society of Clinical Oncology (109)
  3. Wiley Blackwell (104)
  4. Lippincott Williams & Wilkins (85)
  5. Springer (75)
  6. American Association for Cancer Research (41)

More Publishers

Results (948)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Bolus versus continuous intravenous delivery of doxorubicin in soft-tissue sarcomas: Post hoc analysis of a prospective randomized trial (SARC021/TH CR-406)
    Journal Article

    Cranmer, L. D.; Lu, Y.; Heise, R. S.; Ballman, K. V.; Loggers, E. T.; Pollack, S. M.; Wagner, M. J.; Reinke, D. K.; Schöffski, P.; Tap, W. D.
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Safety of intravenous administration of an AAV8 vector coding for an oxidation-resistant human a1-antitrypsin for the treatment of a1-antitrypsin deficiency
    Journal Article

    Rosenberg, J. B.; De, B. P.; Greco, A.; Gorman, N.; Kooner, V.; Chen, A.; Yost-Bido, M.; Munoz-Zuluaga, C.; Kaminsky, S. M.; Rostami, M.; more...
    Human Gene Therapy (2023)

    Fulltext@MSK | Save
  • Final analysis of the phase III non-inferiority COLUMBA study of subcutaneous versus intravenous daratumumab in patients with relapsed or refractory multiple myeloma
    Journal Article

    Usmani, S. Z.; Nahi, H.; Legiec, W.; Grosicki, S.; Vorobyev, V.; Spicka, I.; Hungria, V.; Korenkova, S.; Bahlis, N. J.; Flogegard, M.; more...
    Haematologica (2022)

    Fulltext@MSK | Save
  • Association between the magnitude of intravenous busulfan exposure and development of hepatic veno-occlusive disease in children and young adults undergoing myeloablative allogeneic hematopoietic cell transplantation
    Journal Article

    Bognàr, T.; Bartelink, I. H.; Egberts, T. C. G.; Rademaker, C. M. A.; Versluys, A. B.; Slatter, M. A.; Kletzel, M.; Nath, C. E.; Cuvelier, G. D. E.; Savic, R. M.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Single-agent mosunetuzumab shows durable complete responses in patients with relapsed or refractory b-cell lymphomas: Phase 1 dose-escalation study
    Journal Article

    Budde, L. E.; Assouline, S.; Sehn, L. H.; Schuster, S. J.; Yoon, S. S.; Yoon, D. H.; Matasar, M. J.; Bosch, F.; Kim, W. S.; Nastoupil, L. J.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Intravenous ketamine for cancer pain management, including flares during the COVID-19 pandemic: A retrospective study
    Journal Article

    Oh, D.; Haffey, P.; Patel, A.; Gulati, A.
    Pain Medicine (2021)

    Fulltext@MSK | Save
  • Camidanlumab tesirine in patients with relapsed or refractory lymphoma: A phase 1, open-label, multicentre, dose-escalation, dose-expansion study
    Journal Article

    Hamadani, M.; Collins, G. P.; Caimi, P. F.; Samaniego, F.; Spira, A.; Davies, A.; Radford, J.; Menne, T.; Karnad, A.; Zain, J. M.; more...
    The Lancet Haematology (2021)

    Fulltext@MSK | Save
  • Perspectives from an Onconephrology Interest Group: Conference report
    Review

    Kitchlu, A.; Chan, C. T.; Leung, N.; Chen, S.; Latcha, S.; Tam, P.
    Canadian Journal of Kidney Health and Disease (2020)

    Fulltext@MSK | Save
  • Impact of intraoperative remifentanil on postoperative pain and opioid use in thyroid surgery
    Journal Article

    Wu, J. X.; Assel, M.; Vickers, A.; Afonso, A. M.; Twersky, R. S.; Simon, B. A.; Cohen, M. A.; Rieth, E. F.; Cracchiolo, J. R.
    Journal of Surgical Oncology (2019)

    Fulltext@MSK | Save
  • Consolidation mFOLFOX6 chemotherapy after chemoradiotherapy improves survival in patients with locally advanced rectal cancer: Final results of a multicenter phase II trial
    Journal Article

    Marco, M. R.; Zhou, L.; Patil, S.; Marcet, J. E.; Varma, M. G.; Oommen, S.; Cataldo, P. A.; Hunt, S. R.; Kumar, A.; Herzig, D. O.; more...
    Diseases of the Colon and Rectum (2018)

    Fulltext@MSK | Save